# Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes

Study · id `cardio:ct-nct02408120` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02408120](<https://clinicaltrials.gov/study/NCT02408120>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02408120

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 226 participants.

## Technical summary

Registry record NCT02408120. Randomized; no masking; primary purpose health services research. Start 2015-10 (registry gives no type); primary completion 2019-12-11 (actual). Results posted on 2021-01-06.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose health services research
- Phase: Phase 4
- Enrolled: 226 participants (enrolled count; ClinicalTrials.gov record NCT02408120, source copy `cardio:ctgov-nct02408120-2023-09-28`, retrieved 2026-10-26)
- Start date: 2015-10 (registry gives no type) (ClinicalTrials.gov record NCT02408120, source copy `cardio:ctgov-nct02408120-2023-09-28`, retrieved 2026-10-26)
- Primary completion: 2019-12-11 (actual) (ClinicalTrials.gov record NCT02408120, source copy `cardio:ctgov-nct02408120-2023-09-28`, retrieved 2026-10-26)
- Completion: 2019-12-11 (actual) (ClinicalTrials.gov record NCT02408120, source copy `cardio:ctgov-nct02408120-2023-09-28`, retrieved 2026-10-26)
- Results first posted: 2021-01-06 (ClinicalTrials.gov record NCT02408120, source copy `cardio:ctgov-nct02408120-2023-09-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02408120, source copy `cardio:ctgov-nct02408120-2023-09-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02408120-2023-09-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Insulin glargine
- Intervention (Drug): Insulin aspart
- Intervention (Drug): Supplemental insulin aspart
- Lead sponsor: Emory University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Emory University (`cardio:org-emory-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study (`cardio:pubmed-35675498`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f47b9db3298d107b62c77c40ec6899db0203c2ddda8f56b2521465925054bc69
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
